Wednesday, January 8, 2020

Solara Active Pharma to conduct internal probe on Nizatidine API amid Mylan recall

Solara Active Pharma to conduct internal probe on Nizatidine API amid Mylan recall "We understand from Mylan NV#39;s press release dated January 8, 2020, that Mylan Pharmaceuticals has initiated a voluntary recall of three lots of Nizatidine Capsules, USP (150 mg and 300 mg strengths) due to detected trace amounts of impurity...," Solara Active Pharma Sciences in a filing to BSE.

from Moneycontrol Business News https://ift.tt/36B1RCp
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

FII exodus deepens in 2026 at Rs 1.75 lakh crore as April outflows swell to Rs 43,967 crore; FOMC next trigger

Foreign institutional investors offloaded Indian equities worth Rs 17,140 crore last week, extending April's outflows to Rs 43,967 crore...